EVERSEPT PARTNERS, LP – Viridian Therapeutics, Inc. Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$9.81M
portfolio value
EVERSEPT PARTNERS, LP quarter portfolio value change:
+77.27%
quarter
Viridian Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.36% | 32.79K shares | 4.65M | $20.51 | 478.38K |
| Q2 2022 | share | Increase | +186.11% | 289.84K shares | 2.27M | $11.57 | 445.59K |
| Q1 2022 | share | Decrease | -19.96% | -38.84K shares | -967K | $18.49 | 155.74K |
| Q4 2021 | share | Increase | +21.62% | 34.58K shares | 1.21M | $20.3 | 194.58K |
| Q3 2021 | share | Increase | 0.00% | 160K shares | 2.63M | $16.45 | 160K |